Skip to main content
SpringerLink
Log in

Ethical Considerations in the Conduct of Clinical Pharmacokinetic Studies

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Atiba JO, Taylor G, Pershe RA, Blaschke TF. Plasma antipyrine half-life can be determined from urine data. British Journal of Clinical Pharmacology 23: 715–719, 1987

    Article  PubMed  CAS  Google Scholar 

  • Beauchamp TH, Childress JF. Principles of biomedical ethics, Oxford University Press, New York, 1979

    Google Scholar 

  • Danhof M, Breimer DD. Therapeutic drug monitoring in saliva. Clinical Pharmacokinetics 3: 39–57, 1978

    Article  PubMed  CAS  Google Scholar 

  • Fraser HS, Mucklow JC, Murray S, Davies DS. Assessment of antipyrine kinetics by measurement in saliva. British Journal of Clinical Pharmacology 3: 321–325, 1976

    Article  PubMed  CAS  Google Scholar 

  • James A, Koren G, Milliken J, Soldin S, Prober C. Vancomycin pharmacokinetics and dose recommendations for preterm infants. Antimicrobial Agents and Chemotherapy 31: 52–54, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kinney EL, Trautmann J, Gold JA, Vesell ES, Zelis R. Under-representation of women in new drug trials: ramifications and remedies. Annals of Internal Medicine 95: 495–499, 1981

    PubMed  CAS  Google Scholar 

  • Koren G, James A. Vancomycin dosing in preterm infants: prospective verification of new recommendations. Journal of Pediatrics 110: 797–798, 1987

    Article  PubMed  CAS  Google Scholar 

  • Koup JR, Sack CM, Smith AL, Gibaldi M. Hypothesis for the individualisation of drug dosage. Clinical Pharmacokinetics 4: 460–469, 1979a

    Article  PubMed  CAS  Google Scholar 

  • Koup JR, Slattery JT, Gibaldi M. Single point clearance estimation. Research Communications in Chemical Pathology and Pharmacology 25: 559–564, 1979b

    PubMed  CAS  Google Scholar 

  • Levine RJ. Ethics and regulation of clinical research, 2nd ed., Urban & Schwarzenberg, Baltimore-Munich, 1986

    Google Scholar 

  • Long D, Koren G, James A. Ethics of drug studies in infants: how many samples are required for accurate estimation of pharmacokinetic parameters in neonates? Journal of Pediatrics 111: 918–921, 1987

    Article  PubMed  CAS  Google Scholar 

  • Meffin PJ, Williams RL, Blaschke TF, Rowland M. Application of salivary concentration data to pharmacokinetic studies with antipyrine. Journal of Pharmaceutical Sciences 66: 135–137, 1977

    Article  PubMed  CAS  Google Scholar 

  • Mirkin BL. Drug therapy and the developing human: who cares? Clinical Research 23: 106–113, 1975

    PubMed  CAS  Google Scholar 

  • Saeed MA, Gatens PF. Anterior interosseous nerve syndrome: unusual etiologies. Archives of Physical Medicine and Rehabilitation 64: 182, 1983

    PubMed  CAS  Google Scholar 

  • Schafer A. The ethics of the randomized clinical trial. New England Journal of Medicine 307: 719–724, 1982

    Article  PubMed  CAS  Google Scholar 

  • Svensson CK. Is blood sampling for determination of antipyrine pharmacokinetics in healthy volunteers ethically justified? Clinical Pharmacology and Therapeutics 44: 365–368, 1988

    Article  PubMed  CAS  Google Scholar 

  • Svensson CK. Representation of American Blacks in clinical trials of new drugs. Journal of the American Medical Association 261: 263–265, 1989

    Article  PubMed  CAS  Google Scholar 

  • Taylor G, Blaschke TF. Measurement of antipyrine half-life from urinary drug concentrations. British Journal of Clinical Pharmacology 18: 650–652, 1984

    Article  PubMed  CAS  Google Scholar 

  • Van Boxtel CJ, Wilson JT, Lindgren S, Sjöqvist F. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man. European Journal of Clinical Pharmacology 9: 327–332, 1976

    Article  PubMed  Google Scholar 

  • Vesell ES, Passananti GT, Glenwright PA, Dvorchik BH. Studies on the disposition of antipyrine, aminopyrine, and phenacitin using plasma, saliva, and urine. Clinical Pharmacology and Therapeutics 18: 259–272, 1975

    PubMed  CAS  Google Scholar 

  • Welch RM, De Angelis RL, Wingfield M, Farmer TW. Elimination of antipyrine from saliva as a measure of drug metabolism in man. Clinical Pharmacology and Therapeutics 18: 249–258, 1975

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, Michigan, 48202, USA

    Craig K. Svensson

Authors
  1. Craig K. Svensson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Svensson, C.K. Ethical Considerations in the Conduct of Clinical Pharmacokinetic Studies. Clin-Pharmacokinet 17, 217–222 (1989). https://doi.org/10.2165/00003088-198917040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198917040-00001

Keywords

Search

Navigation